Daptomycin is an antibiotic that kills bacterial cells by disrupting the cell membrane. Daptomycin is primarily active against gram-positive bacteria, and is clinically used to treat complicated infections with drug resistant bacteria, like MRSA or VRE infections. However, it is important to note that daptomycin is not effective in treating pneumonia, as the drug is inactivated by alveolar surfactant. The main adverse effect of daptomycin is myopathy, which can rarely present as rhabdomyolysis.

Key Points

  • Daptomycin
    • Note: This is a distinct drug from dapsone
    • Mechanism
      • Disrupts cell membranes by creating transmembrane channels
        • Causes intracellular leakage and membrane depolarization
        • Ultimately inhibits DNA, RNA, and protein synthesis, leading to bacterial death
    • Clinical Use
      • Gram-positive cocci
        • S. aureus skin infections (esp. MRSA), bacteremia, endocarditis
        • VRE
      • Not used for pneumonia
        • Avidly binds to and is inactivated by alveolar surfactant
    • Adverse Effects
      • Myopathy, Rhabdomyolysis
        • Creatinine kinase (CK) levels may rise due to release from skeletal muscle